Actosmet Tablets 15/850 Milligrams
Pioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
MFDS item code 200802021 · Approved 2008.02.21
This product's status changed to Approval withdrawn on 2025.03.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help control blood sugar in patients with type 2 diabetes. By taking pioglitazone and metformin together, it effectively helps improve blood sugar levels. Thus, it is a suitable treatment for patients who require blood sugar management.
For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding the maximum dose of each component: pioglitazone 30mg and metformin 2500mg. The initial dose of this medicine should be based on the patient's current treatment regimen. 1. Patients whose blood glucose is not adequately controlled with pioglitazone or metformin monotherapy: The dose should be based on the current dose of metformin or pioglitazone. Start with 1 tablet of this medicine once daily and gradually adjust the dose after assessing the adequacy of the treatment response. 2. Patients switching from concomitant pioglitazone and metformin therapy: Patients switching from concomitant pioglitazone and metformin therapy to this medicine may start at the doses of pioglitazone and metformin they were previously receiving. 3. Patients with renal impairment: All dose adjustments should be based on careful assessment of renal function. In general, elderly, debilitated, and malnourished patients should not be titrated to the maximum dose of this medicine. After this medicine is administered to a patient, or when the dose is increased, the patient must be carefully monitored for adverse reactions associated with fluid retention. This medicine should generally be administered in divided doses with meals to reduce gastrointestinal adverse reactions caused by metformin. Sufficient time is needed to assess the adequacy of the treatment response. Ideally, treatment response should be assessed using glycated hemoglobin (HbA1C), which is a better indicator of long-term glycemic control than fasting plasma glucose (FPG). HbA1c reflects blood glucose levels over the preceding 2 - 3 months. In the clinical use of this medicine, if glycemic control measured by FPG does not worsen, administration for an adequate period (8-12 weeks) to assess changes in HbA1C is recommended.
This medication contains metformin and pioglitazone and is primarily used for the treatment of type 2 diabetes. Metformin is excreted by the kidneys, so regular kidney function tests are necessary, as there is a risk of a serious side effect called lactic acidosis in patients with impaired renal function. Lactic acidosis is a rare complication that occurs when lactic acid accumulates abnormally, with symptoms including fatigue, muscle pain, difficulty breathing, and abdominal pain; if any of these symptoms occur, consult a physician immediately. In patients with impaired liver function or those who consume alcohol excessively, the risk of lactic acidosis is increased, so caution is required. Pioglitazone can cause fluid retention, which may worsen heart failure; if symptoms of heart failure such as sudden weight gain, difficulty breathing, or edema occur, seek medical attention promptly. This medication should not be used in specific patient groups such as those with severe heart failure, severe renal impairment, or active bladder cancer. This medication should be administered cautiously to patients with irregular eating habits, those engaged in vigorous exercise, or those taking interacting medications, as there is a risk of hypoglycemia, requiring frequent monitoring of blood sugar levels. Also, it is not used for pregnant or breastfeeding women or pediatric patients, as safety has not been established. Regularly monitor blood sugar, kidney function, liver function, and hematological tests while taking this medication to detect and manage any abnormal signs early. In case of overdose, inform medical personnel immediately to receive appropriate supportive care; metformin can be removed by hemodialysis. Finally, if acute diseases, surgeries, or dehydration occur during treatment, temporarily discontinue use and consult with medical professionals.
Not everyone experiences these, and they can vary from person to person.
This medication can be deteriorated by air or moisture, so it must be stored in a tightly closed container. It is best to maintain the storage temperature between 1 and 30 degrees Celsius.
White to grayish-white elongated convex film-coated tablets, with '15/850' on one side and '4833M' on the other side.
56 tablets (14 tablets/PTP packaging x 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Dalim Biotech Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Metformin Hydrochloride · Pioglitazone Hydrochloride
Prescription medication · Combination
Nexpam Korea Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.